Micro-CT Uncovers Underdiagnosed Emphysema in Early COPD

Underdiagnosed emphysema represents a major clinical challenge in patients evaluated for chronic obstructive pulmonary disease (COPD). Standard clinical computed tomography (CT) primarily measures the percentage of low attenuation area (LAA) to quantify tissue destruction. However, clinical CT has limited spatial resolution, which frequently obscures early alveolar remodeling. Consequently, clinicians often fail to identify subtle parenchymal changes in early-stage disease.

Micro-CT Advances in Underdiagnosed Emphysema Detection

Histopathology provides an accurate standard by measuring the mean linear intercept (MLI) to evaluate airspace enlargement. Nevertheless, conventional manual histology is labour-intensive and prone to significant sampling error. To address this hurdle, researchers developed an automated micro-CT approach to measure MLI across ex vivo lung specimens. High-resolution micro-CT bridges the critical diagnostic gap between macroscopic clinical imaging and microscopic histology.

Key Clinical Insights and Comparative Findings

The study systematically compared micro-CT MLI against clinical CT LAA and conventional histology in 89 patients across varying disease stages. Micro-CT-derived MLI demonstrated a strong correlation with histological MLI measurements. Furthermore, micro-CT effectively identified substantial airspace enlargement in patients with normal clinical CT scans. Specifically, microscopic emphysematous destruction was present in pre-COPD and mild GOLD stages before macroscopic LAA abnormalities emerged.

Clinical Implications for Pulmonary Practice

These findings indicate that conventional CT density thresholds underestimate the true burden of early lung destruction. Therefore, clinicians must recognize that a normal CT LAA score does not exclude active microscopic emphysema. Automated micro-CT analysis offers valuable translational utility for evaluating novel therapeutic agents aimed at halting early disease progression. Ultimately, refining high-resolution imaging biomarkers will enhance early diagnosis and improve patient risk stratification.

Frequently Asked Questions

Q1: Why does clinical CT miss early emphysema?

Clinical CT has a spatial resolution between 600 and 1000 micrometers. Consequently, standard CT cannot detect microscopic alveolar wall destruction before gross airspace enlargement occurs.

Q2: What is the mean linear intercept (MLI)?

The mean linear intercept is an established stereological metric that quantifies alveolar airspace size and structural enlargement in lung tissue.

Q3: How does automated micro-CT improve lung assessment?

Automated micro-CT rapidly scans larger tissue volumes with high resolution. Thus, it reduces manual histological workload and avoids sampling bias.

For practitioners looking to deepen their expertise in managing respiratory disorders and diagnostic imaging, explore relevant professional training through our Pulmonology Speciality Courses.

References

1. Van der Rauwelaert J et al. Uncovering underdiagnosed emphysema: comparative assessment using clinical CT and micro-CT. Eur Radiol. 2026 Aug 26. doi: 10.1007/s00330-026-12831-x. PMID: 42645341.
2. McDonough JE et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567-1575.
3. Koo CW et al. Advanced imaging in chronic obstructive pulmonary disease. Eur Radiol. 2020;30(10):5600-5610.